{"id":"reduced-noradrenaline-use","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1356607","moleculeType":"Small molecule","molecularWeight":"319.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This appears to be a clinical intervention or guideline rather than a traditional pharmaceutical drug. It likely involves strategies to reduce dependence on noradrenaline infusions in critical care settings, potentially through alternative vasopressor agents, improved fluid management, or other hemodynamic optimization techniques. The marketed status suggests it may be a clinical protocol or care bundle developed by AMC-UvA.","oneSentence":"Reduced noradrenaline use refers to a clinical practice or protocol aimed at minimizing the administration of noradrenaline (norepinephrine) in patient care.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:04:23.131Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Septic shock or other conditions requiring vasopressor support in intensive care"}]},"trialDetails":[{"nctId":"NCT05168462","phase":"PHASE4","title":"Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-10-01","conditions":"Cardiogenic Shock, Myocardial Infarction","enrollment":776},{"nctId":"NCT06925646","phase":"","title":"Hand Perfusion and Pulse Oximetry Performance","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-09-01","conditions":"Oxygen Saturation","enrollment":20},{"nctId":"NCT06464510","phase":"PHASE3","title":"Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2024-11-21","conditions":"Septic Shock","enrollment":2800},{"nctId":"NCT06885268","phase":"PHASE3","title":"Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2025-06-25","conditions":"Blood Pressure Management, Intraoperative Hypotension, Non-cardiac Surgery","enrollment":750},{"nctId":"NCT07258875","phase":"NA","title":"Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery","status":"RECRUITING","sponsor":"University of Crete","startDate":"2024-11-27","conditions":"Thoracic Surgery With One-lung Ventilation, VExUS, Fluid Management","enrollment":230},{"nctId":"NCT06849466","phase":"PHASE4","title":"Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-01","conditions":"Chronic Post-Surgical Pain","enrollment":364},{"nctId":"NCT05786599","phase":"PHASE2, PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":50},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT06334549","phase":"PHASE4","title":"A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia","status":"RECRUITING","sponsor":"Dalian Municipal Central Hospital","startDate":"2024-03-05","conditions":"Hypotension Drug-Induced","enrollment":180},{"nctId":"NCT04114799","phase":"NA","title":"Haemodynamical Optimization During Brain Surgery","status":"RECRUITING","sponsor":"University Hospital Hradec Kralove","startDate":"2019-04-01","conditions":"Brain Edema","enrollment":50},{"nctId":"NCT06232473","phase":"PHASE4","title":"Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-01-01","conditions":"Functional Disorder","enrollment":424},{"nctId":"NCT04437485","phase":"PHASE2","title":"eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-10-14","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":46},{"nctId":"NCT02458690","phase":"PHASE2","title":"eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients","status":"COMPLETED","sponsor":"Indiana University","startDate":"2015-07","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":216},{"nctId":"NCT05035888","phase":"NA","title":"Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension","status":"COMPLETED","sponsor":"General Hospital of Ningxia Medical University","startDate":"2022-09-05","conditions":"Adverse Effect","enrollment":80},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT04467086","phase":"PHASE3","title":"Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-01-08","conditions":"Mechanical Ventilation, Sedation, Critical Illness","enrollment":72},{"nctId":"NCT05572723","phase":"PHASE4","title":"Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty","status":"COMPLETED","sponsor":"Baskent University","startDate":"2022-03-01","conditions":"Rhinoplasty, Dexmedetomidine, Remifentanil","enrollment":50},{"nctId":"NCT05035472","phase":"NA","title":"The Potency of Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension","status":"UNKNOWN","sponsor":"General Hospital of Ningxia Medical University","startDate":"2023-01-01","conditions":"Adverse Effect","enrollment":80},{"nctId":"NCT04991259","phase":"NA","title":"To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-08-10","conditions":"Acute Liver Failure","enrollment":60},{"nctId":"NCT02832596","phase":"NA","title":"Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2016-10","conditions":"Blood Pressure, Anesthesia","enrollment":24},{"nctId":"NCT00624650","phase":"PHASE2","title":"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-02","conditions":"Acute Lung Injury","enrollment":33},{"nctId":"NCT03672071","phase":"NA","title":"Effects of Norepinephrine-ephedrine Combination on Maternal Hemodynamics","status":"UNKNOWN","sponsor":"Yuzuncu Yil University","startDate":"2018-09-30","conditions":"Cesarean","enrollment":90},{"nctId":"NCT01942785","phase":"PHASE3","title":"Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2013-10","conditions":"Major Depressive Disorder, Irritability","enrollment":55},{"nctId":"NCT02412189","phase":"NA","title":"Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia","status":"UNKNOWN","sponsor":"Sahlgrenska University Hospital","startDate":"2014-02","conditions":"Blood Pressure, Hematocrit Change, Anesthesia","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Reduced noradrenaline use","genericName":"Reduced noradrenaline use","companyName":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","companyId":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Reduced noradrenaline use refers to a clinical practice or protocol aimed at minimizing the administration of noradrenaline (norepinephrine) in patient care. Used for Septic shock or other conditions requiring vasopressor support in intensive care.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}